Progress in fighting prostate cancer: study demonstrates a novel approach to target enhancer-addicted cancers

https://medicalxpress.com/news/2021-12-approach-enhancer-addicted-cancers.html

"a novel approach to treating prostate cancers fueled by different genetic drivers, which altogether represent upwards of 90% of all prostate cancers... The researchers looked at several prostate cancer models that expressed different oncogenes. They found that blocking the SWI/SNF complex slowed cancer cell growth and induced cell death especially in tumors driven by FOXA1 or androgen receptor. There was no effect on benign prostate cells"